Prednisolone may harm patients with inflammatory diseases

05/19/2013 | PhysiciansBriefing.com

Administering low-dose prednisolone to patients with inflammatory rheumatologic disease without diabetes mellitus can interrupt carbohydrate metabolism, according to a small study in Diabetes Care. "Our findings demonstrate that low-dose prednisolone exerts a major deleterious effect on carbohydrate metabolism. When prescribing glucocorticoids, careful consideration should be given to these potential adverse metabolic effects, and alternative anti-inflammatory agents should be considered," researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI